Skip to main content
SpringerLink
Log in

Medicaid Drug Utilisation Review Under OBRA 1990

Current Issues and Future Directions

  • Leading Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • American Medical Association (AMA), American Pharmaceutical Association (APhA), Pharmaceutical Manufacturers Association (PMA). Principles of drug use review (DUR), Summer, 1991

  • Health Care Financing Administration (HCFA). HCFA 2082 Report, 1990

  • Kralewski JE, Wertheimer A, Ratner E, Geary D. Drug Utilization Review in the Private Sector. Final Report under HCFA Cooperative Agreement, No. 99-C-99169/501 T2, 1990

  • Lederle Laboratories. Impact of OBRA-90 on Medicaid pharmacy providers. Medicaid Pharmacy Bulletin 5: 1–10, 1991

    Google Scholar 

  • Maronde RF. Drug utilization review with online computer capability, United States Department of Health Education and Welfare, Social Security Administration, Office of Research and Statistics, DHEW (SSA) 73–11853, 1972

    Google Scholar 

  • National Pharmaceutical Council (NPC). Pharmaceutical Benefits Under State Medical Assistance Programs. National Pharmaceutical Council, Reston, Virginia, 1991

    Google Scholar 

  • Nye CH. Incompatible goals: experience with the Medicaid program offers lessons about the economics and politics of public-sector health insurance. Health Management Quarterly XIII: 25–28, 1991

    Google Scholar 

  • Pollard M, Coster J. Savings for Medicaid Drug Spending. Health Affairs 8: 196–206, 1991

    Article  Google Scholar 

  • Schulke DG. A Congressional perspective on drug utilization review. Proceedings of Drug Utilization Review Workshop, Rockville, November, 1990

    Google Scholar 

  • Soumerai SB, Ross-Degnan D. Experience of state drug benefit programs. Health Affairs 9: 36–54, 1990

    Article  PubMed  CAS  Google Scholar 

  • US Department of Health, Education, and Welfare. Final Report, Task Force on Prescription Drugs. US Government Printing Office, Washington DC, 1969

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medicaid Bureau, Healthcare Financing Administration, Baltimore, Maryland, 21207, USA, 273 High Rise

    Thomas R. Fulda

  2. Worldwide Healthcare Economics and Policy Research, The Upjohn Company, Kalamazoo, Michigan, USA

    Steven L. Hass

Authors
  1. Thomas R. Fulda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven L. Hass
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dr Hass’s participation in this project derives from his former position with the Office of Research, Health Care Financing Administration, Baltimore, Maryland. The authors’ opinions expressed in this article are not those of the institutions that they represent.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fulda, T.R., Hass, S.L. Medicaid Drug Utilisation Review Under OBRA 1990. PharmacoEconomics 2, 363–370 (1992). https://doi.org/10.2165/00019053-199202050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199202050-00004

Keywords

Search

Navigation